BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26840455)

  • 1. Setdb1, a novel interactor of ΔNp63, is involved in breast tumorigenesis.
    Regina C; Compagnone M; Peschiaroli A; Lena A; Annicchiarico-Petruzzelli M; Piro MC; Melino G; Candi E
    Oncotarget; 2016 May; 7(20):28836-48. PubMed ID: 26840455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The c-MYC-BMI1 axis is essential for SETDB1-mediated breast tumourigenesis.
    Xiao JF; Sun QY; Ding LW; Chien W; Liu XY; Mayakonda A; Jiang YY; Loh XY; Ran XB; Doan NB; Castor B; Chia D; Said JW; Tan KT; Yang H; Fu XY; Lin DC; Koeffler HP
    J Pathol; 2018 Sep; 246(1):89-102. PubMed ID: 29926931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SETDB1 regulates SMAD7 expression for breast cancer metastasis.
    Ryu TY; Kim K; Kim SK; Oh JH; Min JK; Jung CR; Son MY; Kim DS; Cho HS
    BMB Rep; 2019 Feb; 52(2):139-144. PubMed ID: 30545440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smad3-mediated recruitment of the methyltransferase SETDB1/ESET controls
    Du D; Katsuno Y; Meyer D; Budi EH; Chen SH; Koeppen H; Wang H; Akhurst RJ; Derynck R
    EMBO Rep; 2018 Jan; 19(1):135-155. PubMed ID: 29233829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset.
    Ceol CJ; Houvras Y; Jane-Valbuena J; Bilodeau S; Orlando DA; Battisti V; Fritsch L; Lin WM; Hollmann TJ; Ferré F; Bourque C; Burke CJ; Turner L; Uong A; Johnson LA; Beroukhim R; Mermel CH; Loda M; Ait-Si-Ali S; Garraway LA; Young RA; Zon LI
    Nature; 2011 Mar; 471(7339):513-7. PubMed ID: 21430779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of SETDB1 inhibits breast cancer progression by miR-381-3p-related regulation.
    Wu M; Fan B; Guo Q; Li Y; Chen R; Lv N; Diao Y; Luo Y
    Biol Res; 2018 Oct; 51(1):39. PubMed ID: 30309377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone methyltransferase SETDB1 promotes cells proliferation and migration by interacting withTiam1 in hepatocellular carcinoma.
    Zhang Y; Huang J; Li Q; Chen K; Liang Y; Zhan Z; Ye F; Ni W; Chen L; Ding Y
    BMC Cancer; 2018 May; 18(1):539. PubMed ID: 29739365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis.
    Rodriguez-Paredes M; Martinez de Paz A; Simó-Riudalbas L; Sayols S; Moutinho C; Moran S; Villanueva A; Vázquez-Cedeira M; Lazo PA; Carneiro F; Moura CS; Vieira J; Teixeira MR; Esteller M
    Oncogene; 2014 May; 33(21):2807-13. PubMed ID: 23770855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Akt/PKB interacts with the histone H3 methyltransferase SETDB1 and coordinates to silence gene expression.
    Gao H; Yu Z; Bi D; Jiang L; Cui Y; Sun J; Ma R
    Mol Cell Biochem; 2007 Nov; 305(1-2):35-44. PubMed ID: 17577629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High SET Domain Bifurcated 1 (SETDB1) Expression Predicts Poor Prognosis in Breast Carcinoma.
    Zhou Z; Wu B; Tang X; Yang W; Zou Q; Wang H
    Med Sci Monit; 2020 Apr; 26():e922982. PubMed ID: 32305991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
    Wong CM; Wei L; Law CT; Ho DW; Tsang FH; Au SL; Sze KM; Lee JM; Wong CC; Ng IO
    Hepatology; 2016 Feb; 63(2):474-87. PubMed ID: 26481868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitination of Lysine 867 of the Human SETDB1 Protein Upregulates Its Histone H3 Lysine 9 (H3K9) Methyltransferase Activity.
    Ishimoto K; Kawamata N; Uchihara Y; Okubo M; Fujimoto R; Gotoh E; Kakinouchi K; Mizohata E; Hino N; Okada Y; Mochizuki Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Inoue T; Tachibana K; Doi T
    PLoS One; 2016; 11(10):e0165766. PubMed ID: 27798683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target.
    Orouji E; Federico A; Larribère L; Novak D; Lipka DB; Assenov Y; Sachindra S; Hüser L; Granados K; Gebhardt C; Plass C; Umansky V; Utikal J
    Int J Cancer; 2019 Dec; 145(12):3462-3477. PubMed ID: 31131878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A regulatory circuitry comprising TP53,
    Chen B; Wang J; Wang J; Wang H; Gu X; Tang L; Feng X
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Setdb1 histone methyltransferase regulates mood-related behaviors and expression of the NMDA receptor subunit NR2B.
    Jiang Y; Jakovcevski M; Bharadwaj R; Connor C; Schroeder FA; Lin CL; Straubhaar J; Martin G; Akbarian S
    J Neurosci; 2010 May; 30(21):7152-67. PubMed ID: 20505083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins.
    Schultz DC; Ayyanathan K; Negorev D; Maul GG; Rauscher FJ
    Genes Dev; 2002 Apr; 16(8):919-32. PubMed ID: 11959841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SETDB1 induces epithelial‑mesenchymal transition in breast carcinoma by directly binding with Snail promoter.
    Yang W; Su Y; Hou C; Chen L; Zhou D; Ren K; Zhou Z; Zhang R; Liu X
    Oncol Rep; 2019 Feb; 41(2):1284-1292. PubMed ID: 30483750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of SETDB1 possesses prognostic value and promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma.
    Huang J; Huang W; Liu M; Zhu J; Jiang D; Xiong Y; Zhen Y; Yang D; Chen Z; Peng L; Yu Z
    Oncol Rep; 2018 Aug; 40(2):1017-1025. PubMed ID: 29901162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking histone methyltransferase SETDB1 inhibits tumorigenesis and enhances cetuximab sensitivity in colorectal cancer.
    Hou Z; Sun L; Xu F; Hu F; Lan J; Song D; Feng Y; Wang J; Luo X; Hu J; Wang G
    Cancer Lett; 2020 Sep; 487():63-73. PubMed ID: 32473242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ΔNp63 activates EGFR signaling to induce loss of adhesion in triple-negative basal-like breast cancer cells.
    Holcakova J; Nekulova M; Orzol P; Nenutil R; Podhorec J; Svoboda M; Dvorakova P; Pjechova M; Hernychova L; Vojtesek B; Coates PJ
    Breast Cancer Res Treat; 2017 Jun; 163(3):475-484. PubMed ID: 28349272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.